Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis
about
The emerging roles of β-arrestins in fibrotic diseasesAS101 prevents diabetic nephropathy progression and mesangial cell dysfunction: regulation of the AKT downstream pathwayInhibition of tyrosine kinase receptor Tie2 reverts HCV-induced hepatic stellate cell activationEndogenous nerve growth factor regulates collagen expression and bladder hypertrophy through Akt and MAPK pathways during cystitis.Hepatocyte growth factor gene-modified adipose-derived mesenchymal stem cells ameliorate radiation induced liver damage in a rat model.High mobility group box-1 promotes the proliferation and migration of hepatic stellate cells via TLR4-dependent signal pathways of PI3K/Akt and JNKPaediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis.Cyclopamine attenuates acute warm ischemia reperfusion injury in cholestatic rat liver: hope for marginal liversInhibition of mechanical stress-induced hypertrophic scar inflammation by emodin.Targeted TFO delivery to hepatic stellate cells.The cytotoxicity study of praziquantel enantiomersEthyl acetate fraction of Amomum xanthioides improves bile duct ligation-induced liver fibrosis of rat model via modulation of pro-fibrogenic cytokines.Gardenia jasminoides attenuates hepatocellular injury and fibrosis in bile duct-ligated rats and human hepatic stellate cellsAkt mediated phosphorylation of LARP6; critical step in biosynthesis of type I collagen.Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) increases human hepatic stellate cell activation.Hepatic stellate cell-targeted delivery of hepatocyte growth factor transgene via bile duct infusion enhances its expression at fibrotic foci to regress dimethylnitrosamine-induced liver fibrosis.MicroRNA Expression Profiling in CCl₄-Induced Liver Fibrosis of Mus musculus.Transforming growth factor-β (TGF-β)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation.Embryonic liver fodrin involved in hepatic stellate cell activation and formation of regenerative nodule in liver cirrhosis.Hepcidin inhibits Smad3 phosphorylation in hepatic stellate cells by impeding ferroportin-mediated regulation of Akt.Delivery and targeting of miRNAs for treating liver fibrosis.Adverse outcome pathway development from protein alkylation to liver fibrosis.GIV/Girdin is a central hub for profibrogenic signalling networks during liver fibrosis.Bioactive compound reveals a novel function for ribosomal protein S5 in hepatic stellate cell activation and hepatic fibrosis.HOTAIR Epigenetically Modulates PTEN Expression via MicroRNA-29b: A Novel Mechanism in Regulation of Liver Fibrosis.Nod-like receptor protein 3 inflammasome activation by Escherichia coli RNA induces transforming growth factor beta 1 secretion in hepatic stellate cells.Hepatic stellate cells regulate liver immunity to visceral leishmaniasis through P110δ-dependent induction and expansion of regulatory T cells in mice.Schistosoma japonicum egg antigen up-regulates fibrogenesis and inhibits proliferation in primary hepatic stellate cells in a concentration-dependent manner.Activation of hepatic stellate cell in Pten null liver injury model.HS-173, a novel PI3K inhibitor, attenuates the activation of hepatic stellate cells in liver fibrosisFatty acid-binding protein 5 limits the anti-inflammatory response in murine macrophages.Placental growth factor silencing ameliorates liver fibrosis and angiogenesis and inhibits activation of hepatic stellate cells in a murine model of chronic liver disease.MicroRNA-30 Protects Against Carbon Tetrachloride-induced Liver Fibrosis by Attenuating Transforming Growth Factor Beta Signaling in Hepatic Stellate Cells.Thermodynamic Aspects and Reprogramming Cellular Energy Metabolism during the Fibrosis Process.Tyrosine Kinase SYK is a Potential Therapeutic Target for Liver Fibrosis.Tetramethylpyrazine inhibits angiotensin II-induced activation of hepatic stellate cells associated with interference of platelet-derived growth factor β receptor pathways.Hepatic Akt expression correlates with advanced fibrosis in patients with chronic hepatitis C infection.Hepatic stellate cells in inflammation-fibrosis-carcinoma axis.New mechanism in the modulation of carbon tetrachloride hepatotoxicity in rats using different natural antioxidants.Hydroxysafflor yellow A attenuates carbon tetrachloride-induced hepatic fibrosis in rats by inhibiting ERK5 signaling.
P2860
Q26783047-198725B2-A5FA-4B2B-9DEB-757D76563EEEQ28542507-D1A497A3-4895-4100-AE3A-9550751F01F2Q30303127-ABF8FC25-C735-4C38-A164-18CBB6859720Q33662383-06004AE1-5705-4471-9E78-01C88735D2AFQ34689652-78111F7E-18CB-4F56-A57C-0EACE0BC740EQ34734165-C53A1261-BCB6-42CF-B404-450734488AEEQ34992341-18D749AA-458D-42BE-AF11-154EAF043045Q35062521-4F8EE365-C68B-4EBE-A8D7-6C77CDC017DCQ35387975-B22A7AB0-8196-4C69-AE04-2B739C31DDEFQ35944606-2BB348FA-1EA0-4978-BE9A-89ED5C9A4380Q36083496-D57E2B18-D698-4A46-B0F9-2ABB9301EFCFQ36100069-13618F10-50D9-4A2E-8B82-11F61A7B6EC6Q36529136-15B3549E-8310-4368-B8C3-2500704469A7Q36638520-4430303B-B4F3-4463-A054-29E5DDF7CDC6Q36689584-7DA44EFB-589B-4AF5-9690-05D6BA80E7F3Q36848725-5DF70A8A-177F-4A7A-AAAA-5E836BD0A3D5Q37050843-0402F442-F483-444D-A3B4-4B0BCA17FEACQ37234131-4AD2F90D-F24E-4B39-9559-384D848C2FD5Q37295226-5D633D06-0950-4868-8228-F7172FE5A2E1Q37538805-ECD58CD7-FC42-44D2-942B-EE4133162292Q38245905-882642C0-524B-4DCD-B8B2-5EB11758F419Q38932043-147CA95B-8282-47B3-BF30-287450F59FA6Q38973639-52E8DD88-8B58-4981-9014-BC3C7099656AQ39011745-4386829B-EA54-49E3-A33A-DF2D28B72832Q40355962-1E2B6D9F-0005-45BC-88B2-B754413E9504Q40873140-D2B0BCCC-F51D-4616-87B0-9628D109E708Q41043666-4E219DFD-DA39-436B-B621-DBF3025C2BB3Q41640538-B3592EE4-F145-4EF7-B9AD-739F6B37AD4EQ41933634-A9007A67-4AD6-4F88-9BE5-3739936FE520Q42032624-78F4704F-46A4-4997-B229-BA705D7AA590Q42183298-0E5F1F92-5F99-49ED-BC91-B1DB6D469C34Q42365769-4D21548D-C344-4B2E-B0B0-A8A8C9D29857Q42701922-574C185E-9F34-488E-99CA-0D1AE9C7247CQ47282821-380B4420-B00B-44E9-8979-3DF682E88A12Q52656283-E911C342-41AD-4DAF-A672-EC12551617ADQ53058328-80AEFDB2-88EF-4768-B9AB-D78BADE5B458Q53253122-F0400775-F245-4A0D-9AFE-D690EBBED5EEQ53296926-A1C9A327-5E1A-4A11-9662-6F85CC816C12Q53767135-96B7A358-9358-4D0A-9EE7-F7F7C1AD159AQ54302981-3545697D-C2A6-430B-ADFD-1234D153A652
P2860
Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Inhibition of phosphatidylinos ...... rogression of hepatic fibrosis
@ast
Inhibition of phosphatidylinos ...... rogression of hepatic fibrosis
@en
Inhibition of phosphatidylinos ...... rogression of hepatic fibrosis
@nl
type
label
Inhibition of phosphatidylinos ...... rogression of hepatic fibrosis
@ast
Inhibition of phosphatidylinos ...... rogression of hepatic fibrosis
@en
Inhibition of phosphatidylinos ...... rogression of hepatic fibrosis
@nl
prefLabel
Inhibition of phosphatidylinos ...... rogression of hepatic fibrosis
@ast
Inhibition of phosphatidylinos ...... rogression of hepatic fibrosis
@en
Inhibition of phosphatidylinos ...... rogression of hepatic fibrosis
@nl
P2093
P2860
P356
P1433
P1476
Inhibition of phosphatidylinos ...... rogression of hepatic fibrosis
@en
P2093
Gakuhei Son
Jeff Lindquist
Laura W Schrum
Richard A Rippe
P2860
P304
P356
10.1002/HEP.23186
P407
P50
P577
2009-11-01T00:00:00Z